General

Cell Line

hPSCreg name CDIi050-A-1
Cite as:
CDIi050-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 19th April 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator FUJIFILM Cellular Dynamics, Inc. (CDI)
Owner The Michael J. Fox Foundation (MJFF)
Distributors

External Databases

BioSamples SAMEA115496882

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Parkinson's Disease/ GBA N409S
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease

External Databases (Donor)

BioSamples SAMEA115473835

Ethics

Also have a look at the ethics information for the parental line CDIi050-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line CDIi050-A.

Reprogramming method

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line CDIi050-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
Transgene expression
Engineered using nuclease-mediated methodologies to exhibit neomycin resistance under the control of a neuronal-specific promotor. Puromycin resistance was also included in the targeting vector to allow selection of the iPS cell line.